138 related articles for article (PubMed ID: 36921706)
21. Activation of TLR2 enhances tight junction barrier in epidermal keratinocytes.
Yuki T; Yoshida H; Akazawa Y; Komiya A; Sugiyama Y; Inoue S
J Immunol; 2011 Sep; 187(6):3230-7. PubMed ID: 21841130
[TBL] [Abstract][Full Text] [Related]
22. The Effects of Mucopolysaccharide Polysulfate on Steroid-Induced Tight Junction Barrier Dysfunction in Human Epidermal Keratinocytes and a 3D Skin Model.
Koda A; Ishii Y; Kashiwagi A; Fujikawa M; Kikuchi K; Hashimoto R; Ueda Y; Doi T
Skin Pharmacol Physiol; 2023; 36(4):186-194. PubMed ID: 36966539
[TBL] [Abstract][Full Text] [Related]
23. Protective effect of Aquaphilus dolomiae extract-G1, ADE-G1, on tight junction barrier function in a Staphylococcus aureus-infected atopic dermatitis model.
Galliano MF; Bäsler K; Caruana A; Mias C; Bessou-Touya S; Brandner JM; Duplan H
J Eur Acad Dermatol Venereol; 2020 Aug; 34 Suppl 5():30-36. PubMed ID: 32870557
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial tight junctions and barrier function are disrupted by 15(S)-hydroxyeicosatetraenoic acid partly via protein kinase C ε-mediated zona occludens-1 phosphorylation at threonine 770/772.
Chattopadhyay R; Dyukova E; Singh NK; Ohba M; Mobley JA; Rao GN
J Biol Chem; 2014 Feb; 289(6):3148-63. PubMed ID: 24338688
[TBL] [Abstract][Full Text] [Related]
25. Mesenchymal Stem Cells and Extracellular Vesicles Derived from Canine Adipose Tissue Ameliorates Inflammation, Skin Barrier Function and Pruritus by Reducing JAK/STAT Signaling in Atopic Dermatitis.
Kim SY; Yoon TH; Na J; Yi SJ; Jin Y; Kim M; Oh TH; Chung TW
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563259
[TBL] [Abstract][Full Text] [Related]
26. Eicosapentaenoic acid ethyl ester ameliorates atopic dermatitis-like symptoms in special diet-fed hairless mice, partly by restoring covalently bound ceramides in the stratum corneum.
Fujii M; Ohyanagi C; Kawaguchi N; Matsuda H; Miyamoto Y; Ohya S; Nabe T
Exp Dermatol; 2018 Aug; 27(8):837-840. PubMed ID: 29392772
[TBL] [Abstract][Full Text] [Related]
27. Caffeoyl-Prolyl-Histidine Amide Inhibits Fyn and Alleviates Atopic Dermatitis-Like Phenotypes via Suppression of NF-κB Activation.
Jeong H; Shin JY; Lee K; Lee SJ; Chong HJ; Jeong H; Jeon YE; Shin DS; Jang S; Kim KH; Kim SI; Lee YS; Ju BG
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998341
[TBL] [Abstract][Full Text] [Related]
28. Zinc enhances intestinal epithelial barrier function through the PI3K/AKT/mTOR signaling pathway in Caco-2 cells.
Shao Y; Wolf PG; Guo S; Guo Y; Gaskins HR; Zhang B
J Nutr Biochem; 2017 May; 43():18-26. PubMed ID: 28193579
[TBL] [Abstract][Full Text] [Related]
29. Dictamnine ameliorates chronic itch in DNFB-induced atopic dermatitis mice via inhibiting MrgprA3.
Yang N; Shao H; Deng J; Yang Y; Tang Z; Wu G; Liu Y
Biochem Pharmacol; 2023 Feb; 208():115368. PubMed ID: 36493846
[TBL] [Abstract][Full Text] [Related]
30. Epidermal tight junctions in health and disease.
Brandner JM; Zorn-Kruppa M; Yoshida T; Moll I; Beck LA; De Benedetto A
Tissue Barriers; 2015; 3(1-2):e974451. PubMed ID: 25838981
[TBL] [Abstract][Full Text] [Related]
31. Tight junction proteins in the canine epidermis: a pilot study on their distribution in normal and in high IgE-producing canines.
Roussel AJ; Bruet V; Marsella R; Knol AC; Bourdeau PJ
Can J Vet Res; 2015 Jan; 79(1):46-51. PubMed ID: 25673908
[TBL] [Abstract][Full Text] [Related]
32. Bortezomib, a proteasome inhibitor, alleviates atopic dermatitis by increasing claudin 1 protein expression.
Kim YE; Cho N; Cheon S; Kim KK
Biochem Biophys Res Commun; 2017 Nov; 493(1):744-750. PubMed ID: 28859979
[TBL] [Abstract][Full Text] [Related]
33. Osthole attenuates mouse atopic dermatitis by inhibiting thymic stromal lymphopoietin production from keratinocytes.
Fu X; Hong C
Exp Dermatol; 2019 May; 28(5):561-567. PubMed ID: 30825337
[TBL] [Abstract][Full Text] [Related]
34. Immunomodulatory and Anti-inflammatory Effects of Asiatic Acid in a DNCB-Induced Atopic Dermatitis Animal Model.
Moon GH; Lee Y; Kim EK; Chung KH; Lee KJ; An JH
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371956
[TBL] [Abstract][Full Text] [Related]
35. Flightless I over-expression impairs skin barrier development, function and recovery following skin blistering.
Kopecki Z; Yang GN; Arkell RM; Jackson JE; Melville E; Iwata H; Ludwig RJ; Zillikens D; Murrell DF; Cowin AJ
J Pathol; 2014 Apr; 232(5):541-52. PubMed ID: 24375017
[TBL] [Abstract][Full Text] [Related]
36. New mechanism underlying IL-31-induced atopic dermatitis.
Meng J; Moriyama M; Feld M; Buddenkotte J; Buhl T; Szöllösi A; Zhang J; Miller P; Ghetti A; Fischer M; Reeh PW; Shan C; Wang J; Steinhoff M
J Allergy Clin Immunol; 2018 May; 141(5):1677-1689.e8. PubMed ID: 29427643
[TBL] [Abstract][Full Text] [Related]
37. Homeostatic pruning and activity of epidermal nerves are dysregulated in barrier-impaired skin during chronic itch development.
Takahashi S; Ishida A; Kubo A; Kawasaki H; Ochiai S; Nakayama M; Koseki H; Amagai M; Okada T
Sci Rep; 2019 Jun; 9(1):8625. PubMed ID: 31197234
[TBL] [Abstract][Full Text] [Related]
38. Acute modulations in stratum corneum permeability barrier function affect claudin expression and epidermal tight junction function via changes of epidermal calcium gradient.
Baek JH; Lee SE; Choi KJ; Choi EH; Lee SH
Yonsei Med J; 2013 Mar; 54(2):523-8. PubMed ID: 23364991
[TBL] [Abstract][Full Text] [Related]
39. Deacetylasperulosidic Acid Ameliorates Pruritus, Immune Imbalance, and Skin Barrier Dysfunction in 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis NC/Nga Mice.
Oh JS; Seong GS; Kim YD; Choung SY
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008651
[TBL] [Abstract][Full Text] [Related]
40. Th2 Modulation of Transient Receptor Potential Channels: An Unmet Therapeutic Intervention for Atopic Dermatitis.
Meng J; Li Y; Fischer MJM; Steinhoff M; Chen W; Wang J
Front Immunol; 2021; 12():696784. PubMed ID: 34276687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
